PSA Flashcards
What is a well known side effect of ticagrelor in treating patients with ACS?
Dyspnoea
What is the NICE guidance on constipation? (i.e 1st line to 3rd etc)
- Bulk forming laxative (Isphagula husk)
- Osmotic Laxative (Macrogol / lactulose) - if stools hard
- Stimulant (Senna/bisacodyl) - if stools soft but failing to pass NB contraindicated in bowel obstruction.
DVT 1st line ____
DVT in pregnancy 1st line ____
Apixaban
Rivaroxaban
LMWH
Cardiac Arrest - 4Hs and 4Ts
Hypoxia
Hypo/hyperthermia
Hypo/hyperkalaemia
Hypovolaemia
Tension Pneumothorax
Tamponade
Toxins
Thrombosis
Methotrexate monitoring requirements
In view of reports of blood dyscrasias (i.e anaemia, leukopenia, and thrombocytopenia. - including fatalities) and liver cirrhosis with low-dose methotrexate patients should:
**FBC
U+E’s
LFTs **
- every 1–2 weeks until therapy stabilised, thereafter patients should be monitored every 2–3 months.
- be advised to report all symptoms and signs suggestive of infection, especially sore throat
Regular monitoring of _ is required in cyclosporin therapy
Kidney function - U+E’s
A threshold of ____ g/L is used when using a restrictive transfusion threshold. Higher thresholds (usually _____ g/L) are used in acute coronary syndrome and restrictive transfusion is not used in cases of major haemorrhage.
70g/L
80g/L
1 unit of crossmatched blood should be used in patients who are below the threshold and not actively bleeding
2 units of crossmatched blood can be used if patient is actively bleeding
2 units of O- blood should be transfused only in an emergency where there is no time to crossmatch.
Adrenaline doses in:
Anaphylaxis _______
Asystole/PEA _____ (to be repeated every 3-5mins if necessary)
500ug IM (1 in 1000)
1mg IV (1 in 10000)
A systolic BP of ____ mmHg and above is defined as severe hypertension.
Patients with severe hypertension should be referred for same-day specialist review if they have signs of end organ damage:
- on fundoscopy (such as papilloedema or retinal haemorrhage) indicating accelerated hypertension
- if they have signs of end-organ damage (such as confusion, heart failure or AKI)
- or if they have suspected phaeochromocytoma (such as postural hypotension, palpitations or abdominal pain). In this case, there is postural hypotension on examination and therefore a secondary care review is indicated.
180
Omeprazole can cause _____. Therefore it is important to monitor _____ levels before and after starting therapy, particularly in this case when the patient has an underlying arrhythmia and is taking digoxin. Hypomagnesaemia can lead to an increased risk of arrhythmia and digoxin toxicity.
Hypomagnesamia
The BNF states that:
Measurement of serum-magnesium concentrations should be considered before and during prolonged treatment with a proton pump inhibitor, especially when used with other drugs that cause hypomagnesaemia or with digoxin.
Although it is important to monitor other electrolytes in this patient due to the use of ramipril (potential renal impairment) and a loop diuretic (possible hypokalemia, hypochloremia and hypocalcaemia), these are not directly affected by omeprazole.
Omeprazole can cause _____. Therefore it is important to monitor _____ levels before and after starting therapy, particularly in this case when the patient has an underlying arrhythmia and is taking digoxin. Hypomagnesaemia can lead to an increased risk of arrhythmia and digoxin toxicity.
Hypomagnesamia
The BNF states that:
Measurement of serum-magnesium concentrations should be considered before and during prolonged treatment with a proton pump inhibitor, especially when used with other drugs that cause hypomagnesaemia or with digoxin.
Although it is important to monitor other electrolytes in this patient due to the use of ramipril (potential renal impairment) and a loop diuretic (possible hypokalemia, hypochloremia and hypocalcaemia), these are not directly affected by omeprazole.
____ need to be regularly monitored in patients who are prescribed amiodarone due to a key side effect of _____.
TFTs
thyrotoxicosis
Adults
Moderate acute asthma:
Severe acute asthma (Any one of the following):
Life-threatening acute asthma (Any one of the following in a patient with severe asthma):
Near-fatal acute asthma:
Moderate acute asthma:
Increasing symptoms;
Peak flow > 50-75% best or predicted;
No features of acute severe asthma.
Severe acute asthma:
Any one of the following:
Peak flow 33-50% best or predicted;
Respiratory rate ≥ 25/min;
Heart rate ≥ 110/min;
Inability to complete sentences in one breath.
Life-threatening acute asthma:
Any one of the following in a patient with severe asthma:
Peak flow < 33% best or predicted;
Arterial oxygen saturation (SpO2) < 92%;
Partial arterial pressure of oxygen (PaO2) < 8 kPa;
Normal partial arterial pressure of carbon dioxide (PaCO2) (4.6–6.0 kPa);
Silent chest;
Cyanosis;
Poor respiratory effort;
Arrhythmia;
Exhaustion;
Altered conscious level;
Hypotension.
Near-fatal acute asthma:
Raised PaCO2 and/or the need for mechanical ventilation with raised inflation pressures.
Routine serum-lithium monitoring should be performed ____ after initiation and after each dose change until concentrations are stable, then every ____ for the first year, and ____ thereafter.
weekly
3 months
every 6 months
Patients and carers should be advised to seek immediate medical advice if _____ develops whilst taking clozapine.
This is due to the potentially fatal risk of _____ , ____ , and ____.
constipation
intestinal obstruction, faecal impaction and paralytic ileus